William Blair lifted their Q1 2026 earnings estimates for shares of Ionis Pharmaceuticals in a research note issued on ...

Investment analysts at William Blair lowered their FY2025 earnings per share (EPS) estimates for Oracle in a note issued to ...

Chiefs Coach and BYU grad Andy Reid was on hand to watch the Cougars fall behind 15-0. At halftime, the Houston lead was ...

The Maryland-based biopharma joins Eli Lilly and Novo Nordisk in trialing a GLP-1 agonist for alcohol- and liver-related ...

Viking Therapeutics eyes billion-dollar obesity drug markets with pivotal trials and major production deals. Read more about ...

William Blair analyst Andy Hsieh reiterated a Hold rating on Nektar Therapeutics (NKTR – Research Report) today. The company’s shares closed ...

William Blair analyst Tim Mulrooney maintained a Hold rating on ABM Industries (ABM – Research Report) today. The company’s shares opened today ...

Baer also told analysts that Stitch Fix customers span all income levels, and that most U.S. shoppers are unhappy with the current in-store shopping experience for clothing. The executive cited market ...

Fintel reports that on March 12, 2025, William Blair downgraded their outlook for Magic Software Enterprises (NasdaqGS:MGIC) ...

The pain will steadily subside this year, however, as the footwear brand makes progress toward a more profitable distribution ...

Tony Blair was elected Prime Minister in a landslide victory for Labour on May 2, 1997. It ended 18 years of Tory rule.